Search Results - John Muth

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Gonorrhea as a Social Disease

    Gonorrhea as a Social Disease by John J. Potterat, Richard Rothenberg, Donald E. Woodhouse, John Muth, CHRISTOPHER I. PRATTS, JAMES S. FOGLE

    Published 1985
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Epidemiologic differences between chlamydia and gonorrhea.

    Epidemiologic differences between chlamydia and gonorrhea. by Holger Zimmerman, John J. Potterat, RlCHARD L. DUKES, John Muth, H P Zimmerman, JAMES S. FOGLE, CHRISTOPHER I. PRATTS

    Published 1990
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Risk network structure in the early epidemic phase of HIV transmission in Colorado Springs

    Risk network structure in the early epidemic phase of HIV transmission in Colorado Springs by John J. Potterat, Lynanne Phillips‐Plummer, Stephen Q. Muth, Richard Rothenberg, Donald E. Woodhouse, T S Maldonado-Long, H P Zimmerman, John Muth

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia

    Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia by Jayakumar Vadakekolathu, Mark D. Minden, Tressa Hood, S. Church, Stephen Reeder, Heidi Altmann, Amy Sullivan, Elena Viboch, Tasleema Patel, Narmin Ibrahimova, Sarah Warren, Andrea Arruda, Yan Liang, Thomas H. Smith, Gemma A. Foulds, Michael Bailey, James Gowen-MacDonald, John Muth, Marc Schmitz, Alessandra Cesano, A. Graham Pockley, Peter J.M. Valk, Bob Löwenberg, Martin Bornhäuser, Sarah K. Tasian, Michael P. Rettig, Jan K. Davidson-Moncada, John F. DiPersio, Sergio Rutella

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML

    TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML by Jayakumar Vadakekolathu, Catherine Lai, Stephen Reeder, S. Church, Tressa Hood, Anbarasu Lourdusamy, Michael P. Rettig, Ibrahim Aldoss, Anjali S. Advani, John E. Godwin, Matthew J. Wieduwilt, Martha Arellano, John Muth, Tung On Yau, Farhad Ravandi, Kendra Sweet, Heidi Altmann, Gemma A. Foulds, Friedrich Stölzel, Jan Moritz Middeke, Marilena Ciciarello, Antonio Curti, Peter J.M. Valk, Bob Löwenberg, Ivana Gojo, Martin Bornhäuser, John F. DiPersio, Jan K. Davidson-Moncada, Sergio Rutella

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia

    Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia by Geoffrey L. Uy, Ibrahim Aldoss, Matthew C. Foster, Peter H. Sayre, Matthew J. Wieduwilt, Anjali S. Advani, John E. Godwin, Martha Arellano, Kendra Sweet, Ashkan Emadi, Farhad Ravandi, Harry P. Erba, Michael Byrne, Laura C. Michaelis, Max S. Topp, Norbert Vey, Fabio Ciceri, Matteo Giovanni Carrabba, Stefania Paolini, Gerwin Huls, Mojca Jongen‐Lavrencic, Martin Wermke, Patrice Chevallier, Emmanuel Gyan, Christian Récher, Patrick J. Stiff, Kristen Pettit, Bob Löwenberg, S. Church, Erica Anderson, Jayakumar Vadakekolathu, Marianne Santaguida, Michael P. Rettig, John Muth, Teia Curtis, Erin Fehr, Kuo Guo, Jian Zhao, Ouiam Bakkacha, Kenneth Jacobs, Kathy Tran, Patrick Kaminker, Maya Kostova, Ezio Bonvini, Roland B. Walter, Jan K. Davidson-Moncada, Sergio Rutella, John F. DiPersio

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: